A recent ruling from a Delaware Federal judge has confirmed that Galderma’s patent protection covering Oracea is secure, and confirming that generic Oracea is just not going to happen. This most recent ruling found that Amneal Pharmaceuticals’s attempt to create a generic version of the once-daily low dose doxycycline treatment infringes 5 of Galderma’s US […]
The regulator of healthcare products in the UK has issued a Drug Safety Update related to the topical treatment for the red face of rosacea – Mirvaso. This update was issued in June 2017 and seems to have gone largely unnoticed by rosacea sufferers online. Here is why it has been issued, and what […]
News today that Bayer HealthCare is selling its prescription dermatology business to the unlisted Danish company Leo Pharma. Leo Pharma now becomes an interesting company for rosacea sufferers given the prevalence and efficacy of both Finacea and Finacea Foam. The future of these products and any related funded research now rests with Leo Pharma. LEO […]
Does the trip to the doctor, taking the paperwork to the chemist and then negotiating the insurance minefield get you down? Well you are not alone – many rosacea sufferers despair at how much it takes to get hold of your favourite prescription treatment. Well what would it take for the rosacea treatment main stays […]
Rosacea sufferers are suffocating under a pile of research that suggests we are at higher risk of an ever growing list of diseases. This time rosacea sufferers are being told that they have a higher risk of cardiovascular disease compared to non-rosacea sufferers. Here’s what you need to know. Firstly, this research appears to fit […]
